世界の同種移植市場 – 業界動向と2030年までの予測

同種移植市場の地域市場分析と規模

一般人口における骨粗鬆症、変形性関節症、その他の骨疾患の蔓延は、同種移植市場の成長を牽引する主な要因の 1 つです。平均寿命の延長、生活習慣病の発症率の増加、技術の進歩、低侵襲手術に対する消費者の嗜好の高まりが、移植市場の発展を後押ししています。整形外科手術件数の増加、とりわけ肩関節手術などの外科手術の需要が、同種移植市場を牽引しています。                                

データブリッジ市場調査は、2022年に6億7,075万米ドルだった市場規模が2030年までに10億8,346万米ドルに急成長し、予測期間中に5.90%のCAGRを達成すると予測しています。世界中で整形外科疾患が増加しているため、「整形外科」が同種移植市場のアプリケーションセグメントを支配しています。データブリッジ市場調査がまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みが含まれています。

同種移植市場の地域市場の範囲とセグメンテーション

市場の定義

同種移植とは、遺伝子型が異なる人から別の人に移植されることが知られている骨や組織のことです。これらの骨や組織は、血縁関係の有無にかかわらず、生体ドナーの組織や死体骨から採取されます。ドナー標本はレシピエントの双子である必要はありませんが、両者は同じ種である必要があります。         

 世界の同種移植市場の動向

ドライバー

• 慢性疾患や整形外科疾患の罹患率の増加

心血管疾患、糖尿病、変形性関節症などの整形外科疾患などの慢性疾患の発生率の増加により、同種移植の需要が高まっています。同種移植は、損傷または病変組織を置換する外科手術で広く使用されており、患者に実行可能な治療オプションを提供しています。世界の人口が高齢化し、慢性疾患が増加し続けると、同種移植の需要は大幅に増加するでしょう。

• 同種移植の処理と保存における技術的進歩

同種移植片の取り扱いと保管技術の向上により、同種移植片の安全性と有効性が大幅に向上しました。凍結保存、滅菌法、組織バンキングの実践などの革新により、同種移植片の構造的および機能的完全性を維持しながら、同種移植片の保存期間が延長されました。これらの技術の進歩により、同種移植片の入手性と可用性が向上し、市場の成長が促進されました。

• 低侵襲手術への関心が高まる

患者と医療提供者は、回復時間の短縮、術後合併症の減少、患者の転帰の改善など、いくつかの利点がある低侵襲手術を好む傾向が高まっています。同種移植は、小さな切開で簡単に移植できるため、関節鏡検査や腹腔鏡検査などの低侵襲手術でよく使用されます。低侵襲技術の使用が増えるにつれて、同種移植の需要も増加すると予想されます。

• スポーツ医学とスポーツ関連の傷害への注目が高まる

Sports-related injuries such as torn ligaments, tendons, and cartilage damage are common among athletes and the general population. Allografts play a crucial role in sports medicine because they provide transplant options for reconstructive surgery and promote faster healing and tissue regeneration. The growing awareness of sports injuries and the importance of timely intervention and rehabilitation is increasing the demand for allografts in the field of sports medicine. 

Opportunities

• Increasing adoption of precision medicine

Precision medicine, which involves tailoring treatment to individual patients based on their specific genetic, environmental, and lifestyle factors, represents a significant market opportunity. Allografts can play an important role in personalized medicine by providing transplant options that precisely match the patient's biological and immunological characteristics. As the field of precision medicine evolves, the demand for personalized allograft solutions is increasing, creating opportunities for companies to develop and offer customized transplant products and services.

• Growing focus on regenerative therapies

Regenerative therapies, which aim to restore or replace damaged tissues and organs, are receiving considerable attention in medicine. Allografts, especially those containing stem cells or other regenerative components, have enormous potential for regenerative medicine applications. There are opportunities for companies to invest in research and development to improve the regenerative properties of allografts, explore new delivery methods, and develop innovative combination therapies that combine allografts with other regenerative technologies. 

Restraints

• Limited availability of donor tissues

The availability of donor tissues significantly limits the market for allografts. The supply of allografts is highly dependent on the availability of suitable donor tissues, which may be limited. Factors such as donor scarcity, eligibility criteria, and consent issues can limit the availability of allografts, leading to supply shortages and increased costs.

• Risk of disease transmission and graft rejection

Although strict screening and testing protocols exist to ensure the safety of allografts, there is still a tiny risk of donor-to-recipient transmission. Although this risk is minimal, it can be a concern for both patients and healthcare providers. In addition, transplant rejection, where the recipient's immune system attacks the transplanted tissue, remains a challenge that requires immunosuppressive medications and close patient monitoring.

Challenges

• Ethical and legal challenges

The use of allografts presents ethical and legal challenges related to tissue procurement, consent and allocation. Securing appropriate informed support from donors or their families, maintaining donor anonymity, and adhering to ethical guidelines can be difficult, especially in cross-border transactions. In addition, legal frameworks for tissue banking, import/export regulations, and intellectual property rights vary from country to country, presenting challenges for companies operating in the market.

• Cost and reimbursement pressures

Allografts can be expensive due to costs associated with tissue collection, processing, testing, and storage. Reimbursement policies and healthcare budget constraints can create problems in obtaining adequate reimbursement for transplant procedures, especially in public health systems. Pricing pressures and the need to demonstrate cost-effectiveness and long-term clinical benefit can create challenges for companies that can affect market entry and profitability. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In August 2022, orthopedic surgeons at University National Hospital performed the first meniscal transplant and implanted donor cartilage into the patient's knee in Scotland
• In July 2022, AlloSource added a quadricep tendon to its AlloConnex line of tendons, ligaments, and fascia. AlloSource's AlloConnex quadricep tendon is used for cruciate ligament procedures and is available with or without the bone block for various surgical techniques

Allograft Market Regional Market Scope

The market is segmented on the basis of type, application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Demineralized bone (DBM)
• Machined allograft
• Soft tissue allograft
• Others

Application

• Dentistry
• Orthopedic
• Wound care
• Spinal
• Trauma
• Others

End User

• Hospitals
• Specialized clinics
• Ambulatory surgical  centers
• Others

Global Allograft Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, application, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the allograft market due to the growing awareness related to the commercially accessible innovative products, well-developed healthcare structure, increasing number of trauma-related injuries and cases of orthopedic disease and higher healthcare expenditure in the region.   

Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising medical tourism and favourable government initiatives in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to significant or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different products for the market, impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2010-2020.

Competitive Landscape and Market Share Analysis

The competitive market landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the global allograftmarket are:

• ALLERGAN (Ireland)
• B. Braun Melsungen AG (Germany)
• CONMED Corporation (U.S.)
• XTANT MEDICAL (U.S.)
• LeMaitre Vascular, Inc. (U.S.)
• Alliqua (U.S.)
• BD (U.S.)
• Arthrex, Inc. (U.S.)
• Bone Bank Allografts (U.S.)
• Osiris (U.S.)
• インテグラライフサイエンス（米国）
• AlloSource（米国）
• バクスター（米国）
• デピューシンセス（米国）
• メドトロニック（アイルランド）
• NuVasive, Inc.（米国）
• オーソフィックス・ホールディングス（米国）
• スミス・アンド・ネフュー（英国）
• ストライカー（米国）
• ライトメディカルグループNV（米国）
• ジマーバイオメット（米国）

SKU-35739